• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Report: Not-for-Profit Hospitals See Margin Improvements in 2025

by Fred Pennic 04/04/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Fitch Ratings has released a report revealing an improvement in the median financial performance of Fitch-rated not-for-profit (NFP) hospitals and healthcare systems with early fiscal year ends (FYE) in 2024, compared to the previous year. 

– While this positive trend suggests a potential stabilization, full calendar year (CY) 2024 medians are expected to remain below pre-pandemic levels.

NFP Median Operating Margin for Providers

Specifically, the median operating margin for providers with early FYEs rose to 1.2% in CY2024, a substantial increase from the -0.5% reported in CY2023. This improvement is largely attributed to a decrease in personnel costs, notably the continued reduction in contract labor utilization. Personnel costs as a percentage of total operating revenues fell from 55.4% in 2023 to 54.5% in 2024.

Labor Challenges

Despite this positive shift, persistent labor challenges continue to drive base salary and wage expenses upward, resulting in a median year-over-year expense increase of 6.9%. This figure would have been even higher without ongoing efforts to recruit and retain talent, streamline operations, and optimize supply chains. Fitch anticipates that workforce development will remain a critical focus for health systems to address labor shortages and maintain sustainable profitability.

Operating Profitability

Operating profitability also benefited from robust revenue growth, with a median increase of 9.1% for early reporting hospitals. This growth was fueled by higher patient volumes, favorable updates to payor contracts, and improved revenue cycle management.

Hospitals are strategically investing in growth and efficiency projects, with capital spending as a percentage of depreciation increasing to 116.3% in CY2024 from 107.5% in CY2023. This return to pre-pandemic capital spending ratios reflects a focus on developing ambulatory networks and strengthening IT infrastructure, including access points, data analytics, AI, and cybersecurity.

Early CY2024 medians also indicate robust liquidity, with days cash on hand remaining stable at approximately 220 days and cash to debt improving to 178.5% from 170.2%. This liquidity cushion is crucial for navigating ongoing headwinds and macro uncertainties, including potential changes to Medicaid.

Median Medicaid reimbursement

The median Medicaid reimbursement as a percentage of gross patient revenue marginally increased to 16.6% in 2023 from 15.9% in 2019, excluding children’s hospitals, and held steady at 16.2% for hospitals with early 2024 FYE. Conversely, median self-pay reimbursement as a percentage of gross patient revenue has declined from pre-pandemic levels, dropping to 2.0% in 2023 from 2.8% in 2019, excluding children’s hospitals, and to 1.8% for hospitals with early 2024 FYE.

These shifts are partly due to Medicaid policy changes and Affordable Care Act (ACA) expansion. However, potential federal budget cuts that may decrease Medicaid reimbursement and increase uninsured care pose significant risks. Providers, particularly those with a higher proportion of Medicaid patients, may be forced to cut services, close locations, or reduce staff.

“For years, health systems—particularly non-profit hospitals—have struggled to stay afloat, in large part due to rising claims denials that limit the reimbursement they receive for care,” said William Chan, CEO and Co-Founder of Iodine Software. “As payers increasingly use AI to deny claims, providers must counter with AI of their own—to ensure the most accurate and defensible bill is generated from the start. By enabling revenue cycle teams to work at the top of their licenses, hospitals can capture the full value of care, focus on the most impactful cases, and accelerate financial recovery—for both patients and providers.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |